rs367799104
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001364171.2(ODAD1):c.626G>A(p.Ser209Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000922 in 1,551,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S209R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001364171.2 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 20Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ODAD1 | ENST00000674294.1 | c.626G>A | p.Ser209Asn | missense_variant | Exon 8 of 16 | NM_001364171.2 | ENSP00000501363.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152064Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000110 AC: 17AN: 154894 AF XY: 0.000183 show subpopulations
GnomAD4 exome AF: 0.0000893 AC: 125AN: 1399278Hom.: 0 Cov.: 30 AF XY: 0.0000971 AC XY: 67AN XY: 690142 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000118 AC: 18AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74396 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2
The c.515G>A (p.S172N) alteration is located in exon 6 (coding exon 5) of the CCDC114 gene. This alteration results from a G to A substitution at nucleotide position 515, causing the serine (S) at amino acid position 172 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 172 of the CCDC114 protein (p.Ser172Asn). This variant is present in population databases (rs367799104, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CCDC114-related conditions. ClinVar contains an entry for this variant (Variation ID: 262501). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Fraser syndrome 3 Uncertain:1
- -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at